Recent scholarly contributions have posited that VIM's degradation could curtail the proliferation and metastasis of breast cancer cells, thereby underscoring its potential utility as both a biomarker and therapeutic target within the domain of breast oncology.2, 5, 6, 7. Here, VIM is linked to breast carcinoma.